News
QGEN
41.60
-0.94%
-0.40
Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’
TipRanks · 1d ago
Qiagen gains after report of early PE interest including EQT, Advent
TipRanks · 1d ago
Qiagen drawing takeover interest from Advent, EQT, Bloomberg reports
TipRanks · 1d ago
Qiagen jumps after report of takeover interest from EQT, Advent
Seeking Alpha · 1d ago
'Qiagen Draws Early Takeover Interest From EQT, Advent' - Bloomberg
Benzinga · 1d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Zura Bio (ZURA)
TipRanks · 2d ago
Weekly Report: what happened at QGEN last week (0629-0703)?
Weekly Report · 4d ago
How Investors Are Reacting To Qiagen (QGEN) Joining The Russell 1000 Dynamic Index
Simply Wall St · 5d ago
Goldman Sachs Discloses 3.65% Voting Interest in Qiagen
TipRanks · 07/03 20:27
Goldman Sachs reports 2.9% stake in Qiagen via derivatives
TipRanks · 07/03 20:27
Is Qiagen (QGEN) Undervalued Following Its Index Addition And QIAcuity Expansion?
Simply Wall St · 06/29 22:11
Weekly Report: what happened at QGEN last week (0622-0626)?
Weekly Report · 06/29 09:16
Qiagen (QGEN) Gets a Hold from Kepler Capital
TipRanks · 06/26 17:25
QIAGEN reports supervisory board member’s vested share award under MAR rules
TipRanks · 06/25 20:36
Is Qiagen's (QGEN) Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools?
Simply Wall St · 06/25 10:18
Qiagen initiated with a Hold at Kepler Cheuvreux
TipRanks · 06/25 08:40
Barclays Sticks to Their Hold Rating for Qiagen (QGEN)
TipRanks · 06/24 08:25
DZ BANK AG Remains a Buy on Qiagen (QGEN)
TipRanks · 06/24 04:45
Goldman Sachs Discloses 3.07% Stake in Qiagen via Complex Instrument Mix
TipRanks · 06/23 21:14
Bank of America reports 2.95% stake in Qiagen via shares and swaps
TipRanks · 06/23 21:13
More
Webull provides a variety of real-time QGEN stock news. You can receive the latest news about Qiagen through multiple platforms. This information may help you make smarter investment decisions.
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.